Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.
Primary Drug | Male | Female | Total | |
---|---|---|---|---|
Opioids | 34 | 33 | 33 | |
Cocaine | 33 | 33 | 33 | |
Stimulants | 30 | 28 | 30 | |
Hypnotics and sedatives | 37 | 44 | 40 | |
Hallucinogens | 28 | 27 | 28 | |
Volatile inhalants | 24 | 26 | 24 | |
Cannabis | 27 | 27 | 27 | |
Other substances | 31 | 32 | 31 | |
TOTAL | 33 | 34 | 34 |
For information on the countries supplying data and the number of treatment clients in each country see Table TDI-7.
See also ‘General notes for interpreting data’ on the Explanatory notes and help page.
Reitox national reports 2012 — TDI — inpatient treatment centres.
Page last updated: Friday, 26 April 2013